Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors
about
sameAs
LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidenceHLA-F is a surface marker on activated lymphocytesIg-like transcript 4 inhibits lipid antigen presentation through direct CD1d interactionHLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilitiesHigh affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activationHuman inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GRole of non-classical MHC class I molecules in cancer immunosuppressionHLA-dependent tumour development: a role for tumour associate macrophages?Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinomaAlteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinomaClinical implication of human leukocyte antigen (HLA)-F expression in breast cancerSerum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodiesOpen conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1HLA-F complex without peptide binds to MHC class I protein in the open conformer form.MHC-linked and un-linked class I genes in the wallaby.The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model.The LILR family: modulators of innate and adaptive immune pathways in health and disease.Survey of the year 2000 commercial optical biosensor literature.Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity.HLA Class Ib Molecules and Immune Cells in Pregnancy and PreeclampsiaAssociation of HLA-A and Non-Classical HLA Class I Alleles.Structural insights into activation of antiviral NK cell responsesThe positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48.Roles and mechanism of natural killer cells in clinical and experimental transplantation.Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.The Expanding Spectrum of Ligands for Leukocyte Ig-like Receptors.A Comprehensive Gene Expression Meta-analysis Identifies Novel Immune Signatures in Rheumatoid Arthritis Patients.LILRB receptor-mediated regulation of myeloid cell maturation and function.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.HLA-F polymorphisms in a Euro-Brazilian population from Southern Brazil.Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition.
P2860
Q21091044-0B8E719A-26F0-499C-89D1-8A020AA2293FQ24300864-2465951C-7882-4CD8-96AF-3079DD7E5F72Q24313634-07782BFF-E32F-4771-A579-A92861EEABE6Q24314932-B470979D-7A00-4300-94BB-20C4772550C1Q24324563-1739FCDB-4366-4565-9030-9B554955977CQ24678795-D20A027E-ACC4-48D2-92F7-77873BC31E88Q26999722-FF3B0A69-D6CA-4778-8331-16C124C5FAA3Q27022124-74BA23EB-1220-42C3-B4C9-B04CB5E7CBA7Q28252431-7D0A5D41-D4CF-401E-A2ED-6BECDFB2D723Q28265651-BFE6D8C4-A909-4915-B6ED-7D531709B409Q28266906-1524BD77-F2B9-4047-B3C2-3B6D60E3A3C6Q28268159-B77CF661-B144-4777-B0CA-38470E10B466Q28277389-27B353E5-3DC8-40DB-B76B-526C16E33970Q28282824-72346E7A-089B-441A-81C4-9991FFAC908EQ33481981-EC9AA7F4-F3DA-4BC5-AA2D-EF6FE755CB70Q33744070-EEE2F3E9-7186-4A60-BA03-1D2D84884BF8Q33748410-80D34145-4EE0-49D7-86CB-A1A8E0A08366Q34009994-E9924948-D296-4545-A3D7-FB907358A258Q34340048-59217882-D992-4D7C-88E3-042586778BE1Q34464911-5E62856F-5494-4D33-92B1-84BF03159402Q34494545-491D943B-3B9B-441F-9F6C-E53CC32557C7Q34763454-57307482-9190-4D5E-BC1D-08096F2A57F7Q36152723-B10A8ED0-8E9B-453A-8CAD-02A082C50653Q36317668-D1B42C16-F30C-4CDC-A9C3-D4B12B8121DEQ36772177-22F507F3-F5C8-4152-B249-6E957320DD69Q36942362-CBCA9699-EBEE-457E-929C-9CB5012E6A3CQ37755212-A41B97CD-5412-424B-AFA7-1D8970E91F66Q38270735-CA218933-B809-4508-A39E-BC263C052BC4Q38659065-B9844846-8BB6-495A-9F1D-D8152D088A91Q38708560-F23ABCDF-83B7-403E-88FF-756E14429397Q38956228-99FBAB7C-BCB5-42CE-8CAB-058DB6615FF5Q39389817-4FB8E938-A801-4222-94B5-6A547558B784Q40097257-D042A6EB-65BA-4FE6-A06A-957189AD6168Q40151014-7A00D351-E27D-4F9F-BC6E-99226205DBF4Q40463753-B1F1484A-6F82-4401-B3C3-9B0F57BC041FQ40607018-551FC122-7E6B-4F59-AA71-8E0BF889408AQ41333332-5B0F2AC0-863B-4362-A098-FE9D5A50A8A1Q46722989-6A999FFE-2DF8-47CC-8A75-E7BF96D23EA0Q47970420-07CAE528-3393-4C26-AC9F-C74FA380EE72Q48253911-539C61C7-4BF4-481B-970D-14F638616F15
P2860
Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@ast
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@en
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@nl
type
label
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@ast
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@en
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@nl
prefLabel
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@ast
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@en
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@nl
P2093
P2860
P921
P3181
P1476
Functional characterization of ...... ers to ILT2 and ILT4 receptors
@en
P2093
A J McMichael
C A O'Callaghan
G Roncador
J M Bastin
P2860
P304
P3181
P356
10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L
P407
P577
2000-12-01T00:00:00Z